| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Aetna
| Facility | $4,508.00 | $4,508.00 | $4,508.00 | |
Aetna
| Professional | $2,626.40 | $3,253.60 | $3,253.60 | |
United
| Professional | $1,646.40 | $2,352.00 | $8,624.00 |
Oncology (pan-cancer), analysis of minimal residual disease (MRD) from plasma, with assays personalized to each patient based on prior next-generation sequencing of the patient's tumor and germline DNA, reported as absence or presence of MRD, with disease-burden correlation, if appropriate
| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Aetna
| Facility | $4,508.00 | $4,508.00 | $4,508.00 | |
Aetna
| Professional | $2,626.40 | $3,253.60 | $3,253.60 | |
United
| Professional | $1,646.40 | $2,352.00 | $8,624.00 |